Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
David E. Olson, Florence F. Wagner, Taner Kaya, Jennifer Gale, Nadia Aidoud, Emeline Davoine, Fanny Lazzaro, Michel Weïwer, Yanling Zhang, Edward B. Holson
Abstract
David E. Olson, Florence F. Wagner, Taner Kaya, Jennifer Gale, Nadia Aidoud, Emeline Davoine, Fanny Lazzaro, Michel Weïwer, Yanling Zhang, Edward B. Holson
Abstract
We disclose the first small molecule histone deacetylase (HDAC) inhibitor (3, BRD73954) capable of potently and selectively inhibiting both HDAC6 and HDAC8 despite the fact that these isoforms belong to distinct phylogenetic classes within the HDAC family of enzymes. Our data demonstrate that meta substituents of phenyl hydroxamic acids are readily accommodated upon binding to HDAC6 and, furthermore, are necessary for the potent inhibition of HDAC8.
OpenAlex reports 89 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We disclose the first small molecule histone deacetylase (HDAC) inhibitor (3, BRD73954) capable of potently and selectively inhibiting both HDAC6 and HDAC8 despite the fact that these isoforms belong to distinct phylogenetic classes within the HDAC family of enzymes. Our data demonstrate that meta substituents of phenyl hydroxamic acids are readily accommodated upon binding to HDAC6 and, furthermore, are necessary for the potent inhibition of HDAC8.
Key concepts: HDAC8, HDAC6, Chemistry, Histone deacetylase, Hydroxamic acid, Histone deacetylase 2, Gene isoform, HDAC10